Form 4: Clorox Director Russell J. Weiner Increases Stake Through Deferred Stock Units

Clorox Company Director Russell J. Weiner has increased his beneficial ownership in the company by acquiring additional deferred stock units through dividend reinvestment and in lieu of director's fees.

Summary

• Russell J. Weiner, a Director of The Clorox Company, acquired additional Deferred Stock Units (DSUs).
• On May 9, 2025, 131.9466 DSUs were acquired through dividend reinvestment under the Independent Directors' Deferred Compensation Plan.
• On June 30, 2025, an additional 237.3844 DSUs were received in lieu of quarterly director's fees.
• Following these transactions, Mr. Weiner's total beneficial ownership of DSUs increased to 14,944.0206.
• These DSUs are convertible on a 1-for-1 basis into Clorox Common Stock and will be settled upon Mr. Weiner's retirement or other termination of service as a Director.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it indicates continued insider ownership and alignment of interests, though it's a routine compensation event rather than a significant investment decision.

Positives

• Director Russell J. Weiner continues to increase his beneficial ownership in Clorox, indicating alignment with shareholder interests.
• The acquisition of Deferred Stock Units through dividend reinvestment and in lieu of cash fees demonstrates a commitment to long-term investment in the company.

Negatives

• No specific negatives are indicated in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

Deferred Stock Units held by Director Russell J. Weiner will be settled 100% in Clorox common stock upon his retirement or other termination of service as a Director.

Management Comments

• No direct management quotes are provided in this Form 4 filing, which is a transactional report.

Industry Context

This Form 4 filing is a routine disclosure of insider stock ownership changes, common across all publicly traded companies. It reflects standard compensation practices for independent directors, often involving equity-based awards to align their interests with shareholders. It does not provide broader industry trends or competitive insights.

Comparison to Industry Standards

• The practice of compensating directors with deferred stock units and allowing dividend reinvestment into equity is a common corporate governance practice across industries, including consumer goods.
• This aligns director incentives with long-term shareholder value.
• Specific comparable companies like Procter & Gamble (PG) or Kimberly-Clark (KMB) also utilize similar equity-based compensation structures for their board members to foster long-term commitment and ownership.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to increased equity ownership.

Next Steps

• The Deferred Stock Units will be settled in Clorox stock upon the reporting person's retirement or termination of service as a Director.

Key Dates

Keywords

Clorox, CLX, Russell J. Weiner, Director, Deferred Stock Units, Insider Ownership, SEC Form 4, Dividend Reinvestment, Compensation Plan